US Activist Hedge Fund Institutional SEC 13D 13G — July 01, 2026

01-07-2026

J. David Rosenberg, a Senior Partner at Keating Muething and Klekamp PLL, filed a Schedule 13D with the SEC on July 1, 2026, disclosing beneficial ownership of 58,250 shares of EWSB Bancorp, Inc. common stock, representing 5.74% of the outstanding shares. On June 29, 2026, he purchased 20,750 shares at $10 per share in a subscription offering. Rosenberg states the shares were acquired for investment purposes and may engage in discussions regarding extraordinary corporate transactions, though he currently has no specific plans for such actions.

• · Rosenberg has sole voting and dispositive power over all 58,250 shares.
• · The filing indicates Rosenberg may in the future enter into or amend Rule 10b5-1 trading plans and may pledge shares under margin or loan agreements.
• · Rosenberg has not been convicted of any criminal proceeding or been party to adverse securities-related civil proceedings in the last five years.
• · The shares were purchased with personal funds.

01-07-2026

Coastlands Capital LP and related entities filed a Schedule 13G/A disclosing beneficial ownership of 373,322 shares of Adial Pharmaceuticals common stock, representing 14.22% of the 2,625,943 shares outstanding as of June 17, 2026. The filing indicates the shares are held in the ordinary course of business and not for changing control. Pre-funded warrants are excluded due to a 4.99% beneficial ownership limitation.

• · The filing is an amendment (Schedule 13G/A) filed on July 1, 2026.
• · Pre-funded warrants held by the reporting persons are excluded from the beneficial ownership calculation due to a 4.99% limitation.
• · The shares are held directly by Coastlands Capital Partners LP.
• · The reporting persons disclaim membership in a group and beneficial ownership except for pecuniary interest.

01-07-2026

Coastlands Capital LP and related entities filed an amended Schedule 13G disclosing beneficial ownership of 3,835,035 shares of Pasithea Therapeutics Corp. common stock, representing 11.48% of the 33,414,448 shares outstanding as of May 13, 2026. The filing indicates the shares are held in the ordinary course of business and not for changing or influencing control, and excludes pre-funded warrants subject to a 9.99% beneficial ownership limitation.

• · The filing is an amendment (SCHEDULE 13G/A) filed on July 1, 2026, with a date of change of July 1, 2026.
• · The reporting persons include Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, and Matthew D. Perry.
• · All reporting persons disclaim beneficial ownership except for their pecuniary interest, and disclaim membership in a group.
• · The shares are held directly by Coastlands Capital Partners LP.
• · Pre-funded warrants held by the reporting persons are excluded due to a 9.99% beneficial ownership limitation.

01-07-2026

Palantir Technologies Inc. disclosed a 7.4% beneficial ownership stake in Surf Air Mobility Inc., holding 8,248,989 shares of common stock as of June 24, 2026. The filing was made under Rule 13d-1(c) and certifies that the securities were not acquired to change or influence control of the issuer.

• · Palantir's filing is under Rule 13d-1(c), indicating passive investment intent.
• · The filing certifies that shares were not acquired to change or influence control.
• · Surf Air Mobility Inc. is incorporated in Delaware and has its business address in Hawthorne, CA.

01-07-2026

ResMed Inc. filed a Schedule 13G/A with the SEC on July 1, 2026, disclosing beneficial ownership of 1,943,828 ordinary shares of Nyxoah SA, representing a 1.95% stake. The filing indicates that ResMed's holdings remained unchanged from the prior reporting period, with no shares acquired or disposed of, and the percentage ownership decreased slightly due to an increase in Nyxoah's total outstanding shares to 99,926,284 as of June 10, 2026.

• · ResMed's ownership remained unchanged from the prior period, with no shares bought or sold.
• · The filing was made pursuant to Rule 13d-1(c), indicating a passive investment intent.
• · ResMed disclaims beneficial ownership of any shares beyond those explicitly reported.

01-07-2026

Russell Paul Newton filed a Schedule 13G with the SEC on July 1, 2026, disclosing beneficial ownership of 15,273,427 ordinary shares of CoinShares PLC (formerly Odysseus Holdings Ltd), representing 11.59% of the outstanding shares. The filing indicates the shares were acquired and are held in the ordinary course of business, not for changing or influencing control.

• · The filing is made under Rule 13d-1(c) of the Securities Exchange Act of 1934.
• · The issuer was formerly known as Odysseus Holdings Ltd and changed its name on September 22, 2025.
• · Russell Paul Newton certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer.

01-07-2026

Glazer Capital, LLC and Paul J. Glazer filed a Schedule 13G with the SEC on July 1, 2026, disclosing that they have ceased to be beneficial owners of more than 5% of Clearwater Analytics Holdings, Inc. Class A common stock. As of the filing, the Reporting Persons report 0% beneficial ownership, indicating they have fully exited their position in the company.

• · The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
• · The Reporting Persons previously may have been deemed to beneficially own more than 5% of the outstanding shares, but as of the filing date they have ceased to be beneficial owners of more than 5% of the class of securities.
• · Glazer Capital serves as investment manager for certain funds and managed accounts (the 'Glazer Funds') that held the shares.
• · The business address for both Reporting Persons is 250 West 55th Street, Suite 30A, New York, NY 10019.
• · The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

01-07-2026

DTQ (BVI) Ltd, controlled by Bernardo Da Veiga, disclosed beneficial ownership of 1,260,897 shares of Rare Earths Americas, Inc. common stock, representing 6.3% of shares outstanding, in a Schedule 13G filing dated July 1, 2026. The filing indicates the shares are held directly by DTQ (BVI) Ltd, with no dispositive or shared voting power reported by the filer. No prior period data is provided in the filing, so period-over-period comparisons are not available.

• · DTQ (BVI) Ltd is a British Virgin Islands corporation controlled by Bernardo Da Veiga.
• · Bernardo Da Veiga is also an Australian resident (address in Dubai).
• · The filing is made pursuant to Rule 13d-1(d) (passive investor exemption under Section 13(d)).
• · No changes in ownership were reported; the filing is an initial Schedule 13G (date of event: May 7, 2026).
• · No dispositive power or shared voting power is reported – filer has sole voting and dispositive power over all 1,260,897 shares.

01-07-2026

Skylark Partners I, LP filed a Schedule 13G/A with the SEC on July 1, 2026, disclosing beneficial ownership of 100 shares of Astrotech Corp common stock, representing 0.0% of shares outstanding. The filing indicates that the shares were not acquired for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous Schedule 13G.
• · Skylark Partners I, LP is a Texas limited partnership with its business address at 1704 Channel Road, Austin, TX 78746.
• · The filing was made pursuant to Rule 13d-1(c), indicating the filer is a passive investor.
• · The filer certifies that the securities were not acquired to change or influence control of the issuer.

01-07-2026

Kemnay Advisory Services Inc. filed a Schedule 13G/A with the SEC on July 1, 2026, disclosing beneficial ownership of 200,002 shares of Offerpad Solutions Inc. Class A common stock, representing a 4.23% stake as of June 24, 2026. The filing indicates Kemnay holds the shares for investment purposes and does not seek to influence control of the company.

• · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
• · Kemnay Advisory Services Inc. is based in New York, NY, and is incorporated in Delaware.
• · The shares are held for investment purposes under Rule 13d-1(c), with no intent to change or influence control of Offerpad.

01-07-2026

Chutzpah Holdings Ltd and related parties filed an amended Schedule 13D disclosing aggregate beneficial ownership of 4,352,641 shares (38.01%) in Pluri Inc., subject to a 35% ownership blocker. The filing details the expiration of 625,000 CHLP Common Warrants on June 30, 2026, and the issuance of new warrants exercisable at $4.25 per share through September/October 2027. While the reporting persons' aggregate stake is high, the beneficial ownership limitation caps voting and economic control at 35%.

• · CHL's 2,018,014 shares consist of 1,933,415 common shares (407,809 PIPE shares, 1,002,169 from pre-funded warrant exercise, 523,437 Kokomodo consideration shares) and 84,599 common warrants.
• · CHLP holds 1,250,000 common shares and 625,000 warrants (two tranches of 312,500 each, exercisable at $4.25, expiring September 30, 2027 and October 21, 2027).
• · Mr. Weinstein holds 10,769 RSUs total; 6,284 vested, 641 vesting within 60 days (August 25, 2026), and 3,844 unvested.
• · The 625,000 CHLP Common Warrants issued in December 2025 expired unexercised on June 30, 2026.
• · Plantae's 452,702 shares were issued as part of the Kokomodo acquisition consideration.

01-07-2026

Dr. Phillip Frost and affiliated entities filed Amendment No. 28 to their Schedule 13D for OPKO Health, Inc., reporting aggregate beneficial ownership of 255,429,406 shares, representing 34.1% of outstanding common stock as of June 29, 2026. The filing is solely due to a change in the issuer's outstanding share count (746,328,225 shares), with no recent transactions by the reporting persons in the last 60 days.

• · No transactions in OPKO common stock were effected by the reporting persons in the 60 days prior to the filing.
• · Dr. Frost holds options to acquire 2,425,000 shares exercisable within 60 days and 250,000 RSUs vesting within 60 days; an additional 250,000 RSUs are excluded as they do not vest until July 2027.
• · Gamma Trust directly owns 216,706,448 shares (29.0%), Frost Nevada owns 30,127,177 shares (4.0%), and the Philanthropic Foundation owns 2,851,830 shares.
• · The filing is Amendment No. 28, reflecting a long-standing reporting history since the original Schedule 13D filed in February 2007.

01-07-2026

TPG GP A, LLC and affiliated entities (Angelo Gordon & Co., L.P., AG GP LLC, James G. Coulter, and Jon Winkelried) filed an amended Schedule 13D disclosing beneficial ownership of 21,349,053.961 common shares (19.6%) of TPG Twin Brook Capital Income Fund. On June 1, 2026, BDC Holdings purchased 3,966,554.017 common shares at $25.2108 per share (at NAV) using a $100 million capital contribution from an investor, and also acquired 18,463.365 shares via the DRIP in the past 60 days. The filing updates the ownership structure and confirms no other transactions in the past 60 days.

• · The filing is Amendment No. 6 to the original Schedule 13D filed on January 9, 2023.
• · Angelo Gordon directly holds 161,736.426 common shares and is the investment advisor to BDC Holdings.
• · BDC Holdings directly holds 21,187,317.535 common shares (excluding DRIP shares).
• · Angelo Gordon and BDC Holdings directly hold 1,126.168 and 244,270.618 common shares, respectively, received via DRIP.
• · The purchase price of $25.2108 per share was equal to the NAV per share as of May 31, 2026, determined by the issuer on June 29, 2026.
• · No other transactions in common shares were effected by reporting persons in the past 60 days.

01-07-2026

Ronald S. Boreta, CEO and Director of Agassi Sports Entertainment Corp. (AASP), filed an amended Schedule 13D reporting a combined beneficial ownership of 2,509,403 shares (19.2% of outstanding common stock) as of June 30, 2026. The filing details an intra-family transfer of 1,495,390 shares from All-American Golf Center, Inc. to the Boreta Lifetime Trust for estate planning, as well as recent open-market and private purchases of 51,000 shares at $5.00 per share. No plans for major corporate changes were disclosed.

• · On February 3, 2026, Boreta Trust purchased 1,000 shares at $5.00 per share in open market.
• · On March 13, 2026, Boreta Trust purchased 50,000 shares at $5.00 per share in a private offering with piggy-back registration rights for three years.
• · On June 30, 2026, AAGC transferred 1,495,390 shares to Boreta Trust for no consideration (estate planning).
• · No shares were sold or disposed of by Reporting Persons in the last 60 days.
• · Reporting Persons have no current plans for mergers, asset sales, board changes, or other major corporate actions.

01-07-2026

Dr. Niclas Adler filed an amended Schedule 13D/A with the SEC on July 1, 2026, reporting beneficial ownership of 1,260,246,354 shares of Edgemode, Inc. common stock, representing 29.45% of the company. The shares were originally acquired pursuant to a Share Exchange Agreement dated April 7, 2025, and no additional shares have been acquired since the prior filing on August 20, 2025.

• · The filing is an amendment (SC 13D/A) to a prior Schedule 13D filed on August 20, 2025.
• · The shares were acquired via a Share Exchange Agreement dated April 7, 2025.
• · No new shares have been acquired since the prior filing.
• · Edgemode, Inc. was formerly known as Fourth Wave Energy, Inc. (name change April 15, 2020), Pierre Corp. (name change November 13, 2018), and Wadena Corp. (name change September 11, 2015).
• · The company is classified under SIC 8082 (Services-Home Health Care Services) and incorporated in Nevada.

01-07-2026

Corre Partners Management, LLC and related entities filed a Schedule 13D/A exit filing for NN, Inc., disclosing that as of June 30, 2026, they ceased to be beneficial owners of more than 5% of NN's common stock. The group now beneficially owns 2,153,637 shares (4.0% of shares outstanding), down from a prior above-5% position. The filing notes ongoing discussions with NN's management and the potential for future actions including additional purchases, sales, or engagement in corporate transactions.

• · The Reporting Persons hold common stock purchase warrants exercisable at $11.03 per share, subject to a 9.99% beneficial ownership limitation.
• · The warrants were issued under a Securities Purchase Agreement dated December 5, 2019.
• · All previously held Series B Convertible Preferred Stock has been redeemed by the Issuer for cash.
• · The Reporting Persons have had discussions with NN's representatives and management and may engage in future communications regarding corporate strategy, board composition, or potential transactions.
• · No borrowed funds were used to purchase the shares, other than ordinary course working capital leverage.

01-07-2026

Daniel E. Stone and his entity RK Stone Miami, LLC filed an amended Schedule 13G on July 1, 2026, reporting combined beneficial ownership of 9.9% of Scinai Immunotherapeutics Ltd.'s ordinary shares (based on 20,053,835,584 shares outstanding as of June 3, 2026). This filing reflects a decrease from the previously reported 17.02% ownership in January 2025, primarily due to share issuances by the company that diluted the reporting persons' stake while their warrant exercise was limited by a 9.99% beneficial ownership cap.

• · Scinai Immunotherapeutics was formerly known as BiondVax Pharmaceuticals Ltd. (name changed on June 24, 2014).
• · The filing is under Rule 13d-1(c), indicating the reporting person is a passive investor.
• · The beneficial ownership cap of 9.99% prevents RK Stone Miami, LLC from exercising additional warrants that would exceed this threshold.
• · Future issuances of ordinary shares or ADSs to third parties may cause additional pre-funded warrants to become exercisable without increasing reporting person's ownership percentage.

01-07-2026

CIM Group Holdings, LLC and its control persons (Richard Ressler, Avraham Shemesh, Shaul Kuba) filed a Schedule 13D disclosing that, following a series of transactions on June 24, 2026, they now beneficially own 907,376,073.66 shares of Special Voting Preferred Stock and an equal number of New OP Class A LP Units, representing approximately 67.5% economic and voting ownership of CIM Group, Inc. (the Issuer). The transactions involved the Issuer acquiring the real assets management business and portfolio of Legacy CIM, with CIM Group Holdings contributing all equity of the contributed entities plus $1,000 cash in exchange for its stake. The filing notes that Messrs. Ressler, Shemesh and Kuba disclaim beneficial ownership except to the extent of their pecuniary interest, and that Ressler serves as Chairman and CEO of the Issuer while Shemesh and Kuba are expected to be appointed to the Board.

• · The filing is a Schedule 13D (not a 13G), indicating an active/influential ownership intent.
• · The filing date is July 1, 2026, with the transaction occurring on June 24, 2026.
• · CIM Group Holdings’ address: 4700 Wilshire Blvd, Los Angeles, CA 90010.
• · Issuer’s address: 2398 East Camelback Road, 4th Floor, Phoenix, AZ 85016.
• · The Reporting Persons disclaim beneficial ownership of the reported shares except for pecuniary interest, and include disclaimers for each of Ressler, Shemesh, and Kuba.

01-07-2026

Marathon Bank 401(k) Plan Trust filed a Schedule 13G/A disclosing beneficial ownership of 216,071 shares of Marathon Bancorp, Inc. common stock, representing 7.32% of shares outstanding as of June 30, 2026. The trust is an employee benefit plan and holds the shares in the ordinary course of business, not for control purposes.

• · The filing is an amendment (SCHEDULE 13G/A) to a previous Schedule 13G.
• · The trust is organized under the laws of Wisconsin.
• · The trust disclaims beneficial ownership of all shares reported.
• · The filing certifies that the securities were acquired and are held in the ordinary course of business and not for changing or influencing control.

01-07-2026

JPMorgan Chase Bank, N.A. filed an amended Schedule 13G/A with the SEC on July 1, 2026, reporting that it beneficially owns 0% of the Remarketable Variable Rate MuniFund Term Preferred Shares, Series 2051 (RVMTP Shares) of MFS Investment Grade Municipal Trust (CXH). The filing indicates JPMorgan held zero shares as of June 8, 2026, a complete reduction from any prior position, and the ownership percentage is calculated based on total preferred shares outstanding as supplied by the issuer.

• · The filing is an amendment (SC 13G/A) filed under Rule 13d-1(b), indicating the shares were acquired and held in the ordinary course of business and not for changing or influencing control of the issuer.
• · JPMorgan's business address is 1111 Polaris Parkway, Columbus, OH 43240.
• · The issuer's fiscal year ends November 30.
• · The filing date is July 1, 2026, with the event date of change also July 1, 2026.

01-07-2026

JPMorgan Chase Bank, N.A. filed a Schedule 13G/A with the SEC on July 1, 2026, reporting that it beneficially owns 0% of the Remarketable Variable Rate MuniFund Term Preferred Shares, Series 2051 of MFS High Yield Municipal Trust (CMU). The filing indicates that JPMorgan holds no shares in the class, representing 0% ownership of the preferred shares outstanding, and the securities were acquired and are held in the ordinary course of business without intent to influence control.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b).
• · The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• · The filing date is July 1, 2026, with a date of change also July 1, 2026.

01-07-2026

JPMorgan Chase Bank, N.A. filed a Schedule 13G/A with the SEC on July 1, 2026, disclosing beneficial ownership of 0 Remarketable Variable Rate MuniFund Term Preferred Shares (RVMTP Shares), Series 2051, of MFS High Income Municipal Trust (CXE). The filing indicates JPMorgan holds 0% of the outstanding preferred shares, representing a reduction from any prior position, and the securities are held in the ordinary course of business without intent to influence control.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b).
• · JPMorgan Chase Bank, N.A. is a bank (BK) and the filing is made on behalf of the institution.
• · The filing date is July 1, 2026, with the event date of June 8, 2026.
• · The issuer's CUSIP for the RVMTP Shares is 59318D708.
• · JPMorgan certifies the securities were acquired and are held in the ordinary course of business, not for changing or influencing control.

01-07-2026

JPMorgan Chase Bank, N.A. filed an amended Schedule 13G disclosing beneficial ownership of 2,241 Remarketable Variable Rate MuniFund Term Preferred Shares (RVMTP Shares), Series 2051, in MFS Municipal Income Trust (MFM), representing 100.00% of the preferred shares outstanding. The filing details that JPM has assigned certain voting rights to a Voting Trust and deposited 967 RVMTP Shares into a tender option bond trust, while 1,274 RVMTP Shares were acquired indirectly through the cashless exchange of shares from predecessor Target Funds (CXE, CMU, CXH) into the Issuer.

• · Voting rights on RVMTP Shares were partially assigned to a Voting Trust (created July 20, 2021) with Glass, Lewis & Co., LLC acting as Voting Trustee and Voting Consultant; the Voting Consultant's recommendations are binding on the Trustee.
• · The 1,274 RVMTP Shares acquired via cashless exchange from Target Funds (CXE, CMU, CXH) were deposited into three separate series of J.P. Morgan Taxable Putters/Taxable Drivers trusts.
• · The filing certifies that securities were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.
• · The filing date is July 01, 2026, with the event date as of June 08, 2026.

01-07-2026

Forsakringsaktiebolaget Avanza Pension filed a Schedule 13G/A with the SEC on July 1, 2026, disclosing beneficial ownership of 1,300,822 shares of Hyperion DeFi, Inc. (HYPD) common stock, representing an 8.58% stake. The filing indicates the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · Forsakringsaktiebolaget Avanza Pension is organized under the laws of Sweden and classified as an insurance company (FI).
• · The shares are held with sole voting power and sole dispositive power over all 1,300,822 shares.
• · The issuer's common stock has a par value of $0.001 per share.
• · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.

01-07-2026

Camac Partners, LLC and related entities (Camac Capital, LLC, Camac Fund, LP, and Eric Shahinian) filed a Schedule 13G/A with the SEC on July 1, 2026, disclosing beneficial ownership of 404,743 shares of TruBridge, Inc. common stock, representing 2.7% of the 14,999,136 shares outstanding as of May 5, 2026. The filing indicates the shares are held in the ordinary course of business and not for changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b).
• · Camac Fund, LP directly holds the 404,743 shares; the other entities and Eric Shahinian may be deemed beneficial owners due to control relationships.
• · The ownership percentage is based on 14,999,136 shares outstanding as reported in TruBridge's Form 10-Q filed on May 8, 2026.
• · The reporting persons certify the securities were acquired and are held in the ordinary course of business, not to change or influence control.

01-07-2026

PW Partners Atlas Fund IV LP and related entities have reduced their beneficial ownership in BJ's Restaurants Inc (BJRI) to below 5%, filing a Schedule 13D/A on July 1, 2026. As of June 24, 2026, the group beneficially owns 550,701 common shares, representing approximately 2.6% of outstanding shares, down from a prior stake above 5%. The reduction was achieved through a series of open-market sales in May and June 2026, including a large sale of 413,670 shares by PW Partners Atlas Fund IV LP on June 20 at an average price of $54.06.

• · PW Partners Atlas Fund IV LP sold 38,105 shares on June 18 at $54.59, 16,225 shares on June 19 at $53.34, and 413,670 shares on June 20 at $54.06.
• · PW Partners Atlas Fund LP sold a total of 13,500 shares between May 1 and June 4, 2026, at prices ranging from $37.78 to $44.15.
• · Patrick Walsh sold 40,000 shares on June 24 at $54.47, plus additional sales between May 8 and June 24 at prices from $41.51 to $54.33, including 20,532 shares related to equity compensation and 8,805 shares via same-day exercise and sale of stock options.
• · The reporting persons ceased to be beneficial owners of more than 5% of outstanding common shares as of June 24, 2026.

01-07-2026

Select Medical Holdings Corp. was taken private via a merger that closed on June 30, 2026, with shareholders receiving $16.50 per share in cash. As a result, reporting persons Robert A. Ortenzio, Martin F. Jackson, and the Estate of Rocco A. Ortenzio now beneficially own zero shares, and the stock was suspended from trading on the NYSE effective July 1, 2026. This amendment serves as an exit filing for these insiders, who rolled their shares into equity of the new parent entity.

• · The merger was consummated on June 30, 2026, and the stock was suspended from trading on the NYSE effective July 1, 2026.
• · The NYSE filed a Form 25 to delist the shares and terminate registration under Section 12(b) of the Exchange Act.
• · Insiders entered into amended and restated rollover agreements to exchange their shares for equity in the parent company (Stallion Group Parent, LP) instead of receiving cash.
• · The rollover was structured as a two-step contribution: first to Intermediate for common stock, then to Parent for Class A units.
• · The rollover agreements were designed to qualify for tax-deferred treatment under Sections 351 and 721(a) of the Internal Revenue Code.

01-07-2026

Bard Associates, Inc. filed an amended Schedule 13G with the SEC on July 1, 2026, reporting that it no longer holds any shares of Perfect Moment Ltd. common stock. The filing indicates a complete exit of the institutional investment advisor's position in the apparel company.

• · Bard Associates, Inc. is an investment advisor (IA) based in Chicago, Illinois.
• · The filing is an amendment to a previous Schedule 13G, indicating a change in ownership from a prior position to zero.
• · The filing certifies the securities were held in the ordinary course of business and not for changing or influencing control of the issuer.